(Q36177768)

English

CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

Christel Herold-Mende

5

object named as

Christel Herold-Mende

0 references

author name string

Seyed Y Ardebili

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Irena Zajc

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Boris Gole

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Benito Campos

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sara Drmota

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Tamara T Lah

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

3 June 2011

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Radiology and Oncology

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

45

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

102-115

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Antigen expression on recurrent meningioma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Insight into the complex regulation of CD133 in glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Glioma cell populations grouped by different cell type markers drive brain tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

CD133 as a marker for cancer stem cells: progresses and concerns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

How powerful is CD133 as a cancer stem cell marker in brain tumors?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cancer stem cells and glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

The 2007 WHO classification of tumours of the central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cysteine cathepsins and the cutting edge of cancer invasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Angiogenesis-independent tumor growth mediated by stem-like cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Antiprotease therapy in cancer: hot or not?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cancer stem cells in the mammalian central nervous system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cathepsin L is required for endothelial progenitor cell-induced neovascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Identification of a cancer stem cell in human brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Proteases in brain tumour progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Tumour-cell invasion and migration: diversity and escape mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Stem cells, cancer, and cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Clinical and experimental studies of cysteine cathepsins and their inhibitors in human brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Unraveling the role of proteases in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Cathepsin B expression in human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

1 October 2017

Different angiogenic phenotypes in primary and secondary glioblastomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

2 July 2018

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Cathepsin L in glioma progression: comparison with cathepsin B.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Cell culture. Progenitor cells from human brain after death.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Differentiation therapy exerts antitumor effects on stem-like glioma cells

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Stem cell marker CD133 affects clinical outcome in glioma patients.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival

1 reference

https://api.crossref.org/works/10.2478%2FV10019-011-0015-6

21 January 2018

The progression of gliomas is associated with cancer stem cell phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423731

23 September 2018

Opinion: the origin of the cancer stem cell: current controversies and new insights

1 reference

https://pubmed.ncbi.nlm.nih.gov/22933943

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2478/V10019-011-0015-6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36177768&oldid=1989971321"